Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Batlle

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Kidney International|May 20, 2003
Clinical and cellular markers of diabetic nephropathyDaniel Batlle
Thescientificworldjournal|March 21, 2006
Carlos Margarit in memoriam, 1950-2005Daniel Batlle
Hypertension (Dallas, Tex. : 1979)|November 1, 2021
Tribute to Lewis Landsberg: A Giant of Academic MedicineDaniel Batlle
The New England Journal of Medicine|July 4, 2008
Images in clinical medicine. Bilateral kidney calcificationsAndres Serrano, Daniel Batlle
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Jan Wysocki, Daniel Batlle
Kidney360|January 2, 2023
ACE2 in the Urine: Where Does It Come From?Jan Wysocki, Daniel Batlle
Kidney International|September 24, 2019
Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?Alonso Marquez, Daniel Batlle
Advances in Chronic Kidney Disease|August 25, 2018
Renal Tubular Acidosis and the Nephrology Teaching ParadigmDaniel Batlle, Jose Arruda
Nature Reviews. Nephrology|February 22, 2022
Potential SARS-CoV-2 kidney infection and paths to injuryLuise Hassler, Daniel Batlle
Advances in Chronic Kidney Disease|August 25, 2018
Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological AspectsDaniel Batlle, Jose Arruda
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Kidney International|May 20, 2003
Clinical and cellular markers of diabetic nephropathyDaniel Batlle
Thescientificworldjournal|March 21, 2006
Carlos Margarit in memoriam, 1950-2005Daniel Batlle
Hypertension (Dallas, Tex. : 1979)|November 1, 2021
Tribute to Lewis Landsberg: A Giant of Academic MedicineDaniel Batlle
The New England Journal of Medicine|July 4, 2008
Images in clinical medicine. Bilateral kidney calcificationsAndres Serrano, Daniel Batlle
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Jan Wysocki, Daniel Batlle
Kidney360|January 2, 2023
ACE2 in the Urine: Where Does It Come From?Jan Wysocki, Daniel Batlle
Kidney International|September 24, 2019
Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?Alonso Marquez, Daniel Batlle
Advances in Chronic Kidney Disease|August 25, 2018
Renal Tubular Acidosis and the Nephrology Teaching ParadigmDaniel Batlle, Jose Arruda
Nature Reviews. Nephrology|February 22, 2022
Potential SARS-CoV-2 kidney infection and paths to injuryLuise Hassler, Daniel Batlle
Advances in Chronic Kidney Disease|August 25, 2018
Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological AspectsDaniel Batlle, Jose Arruda
Pageof 16